# Commission Regulation (EC) No 205/2006 of 6 February 2006 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards toltrazuril, diethylene glycol monoethyl ether and polyoxyethylene sorbitan monooleate (Text with EEA relevance), Division 2.4.1: Triazinetrione derivatives

Extent: E+W+S+N.I.

Not for use in animals from which milk is produced for human consumption.
For porcine species this MRL relates to “skin and fat in natural proportions”.
Not for use in animals from which eggs are produced for human consumption.’
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Toltrazuril
Toltrazuril sulfone
All mammalian food producing species
100 μg/kg
Muscle
150 μg/kg
Fat
500 μg/kg
Liver
250 μg/kg
Kidney
Poultry
100 μg/kg
Muscle
200 μg/kg
Skin + fat
600 μg/kg
Liver
400 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2006/205/annex/division/A/division/2/division/2.4/division/2.4.1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2006-205/annex/division-A/division-2/division-2.4/division-2.4.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.